Business Context and Reporting Period
Company: Alterity Therapeutics Limited (a development stage enterprise)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2026
Principal Executive Office: Level 15, 500 Collins Street, Melbourne, Victoria 3000, Australia
Significant Event: The registrant is scheduled to present at the ASX SMIDcaps Conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. As a development stage enterprise, this Form 6-K serves as a notification of a corporate event rather than a financial results report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this document.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the company's participation in the ASX SMIDcaps Conference.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Unusual Items: None reported.
Investor Verification Checklist
- Verify the date and agenda of the upcoming ASX SMIDcaps Conference presentation.
- Review the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this filing contains none.
- Confirm the status of the company's development stage operations and pipeline progress.
- Check for any subsequent press releases regarding the outcomes of the conference presentation.